Weekly signal · ROIV · Healthcare

Roivant Sciences Ltd (ROIV) surges 16.9% as weekly turnover expands

The biotechnology name extended a three-month advance, but Relative Strength at 39.1 keeps the confirmation from looking broad-based.

Roivant Sciences Ltd
Latest40.82 USD
1W move16.9%
Volume1.5x
TrendActive
Biotechnology lab equipment beside a financial data terminal, representing Roivant Sciences market coverage.

Market update

What happened

Roivant Sciences Ltd (ROIV) closed at 40.82 USD in the latest weekly market data, with the 52-week weekly price path showing a sharp move higher into the latest reading. The stock’s four-week return stands at 12.8%, keeping recent performance positive beyond the latest week.

Confirming evidence includes an active trend reading and Market Dynamics at 0.8, both pointing to continued pressure behind the move. Turnover was also elevated, with 48.3 million shares traded versus a 13-week average of 32.2 million.

Continue your research

Explore ROIV across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

ROIV coverage

Evidence context